 | Up a level |
Wolf, Sebastian; Holz, Frank G; Korobelnik, Jean-François; Lanzetta, Paolo; Mitchell, Paul; Prünte, Christian; Schmidt-Erfurth, Ursula; Weichselberger, Andreas; Hashad, Yehia (2011). Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR. British journal of ophthalmology, 95(12), pp. 1713-8. London: BMJ Publishing Group 10.1136/bjophthalmol-2011-300471
Massin, Pascale; Bandello, Francesco; Garweg, Justus G; Hansen, Lutz L; Harding, Simon P; Larsen, Michael; Mitchell, Paul; Sharp, Dianne; Wolf-Schnurrbusch, U E K; Gekkieva, Margarita; Weichselberger, Andreas; Wolf, Sebastian (2010). Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes care, 33(11), pp. 2399-405. Alexandria, Va.: American Diabetes Association 10.2337/dc10-0493
Holz, Frank G; Korobelnik, Jean-François; Lanzetta, Paolo; Mitchell, Paul; Schmidt-Erfurth, Ursula; Wolf, Sebastian; Markabi, Sabri; Schmidli, Heinz; Weichselberger, Andreas (2010). The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model. Investigative ophthalmology & visual science, 51(1), pp. 405-12. Hagerstown, Md.: Association for Research in Vision and Ophthalmology 10.1167/iovs.09-3813
